Allergy-Immunology
Cardiology
Endocrinology
Gastroenterology
General Internal Medicine
Geriatric Medicine
Hematology / Oncology
Hepatology
Hospital Medicine
Immunotherapy
Infectious Diseases
Nephrology / Hypertension
Pulmonary & Critical Care
Rheumatology
Sports Medicine

Joseph Bass, MD, PhD

Assistant Professor of Medicine

Medical School
The Medical College of Pennsylvania (MD/PhD)

Residency
Rush-Presbyterian St. Lukes' Medical Center, IL

Endocrine Fellowships
University of Chicago Medical School, IL

Board Certified
American Board of Internal Medicine 1994;
Endocrinology and Metabolism 1997

Cell and Molecular Regulation of Body Weight, Feeding and Metabolism

The focus of our research is on insulin signaling and the neuroendocrine regulation of body weight and energy balance.  We are using a combination of genetic and cell biological approaches to investigate the molecular basis of obesity and diabetes, two rising epidemics in the US.  In studies based on our analysis of humans with congenital insulin resistance, an inherited subtype of diabetes, we have identified new missense mutations in the insulin receptor gene (IR).  Studies at a cellular level have translated our analysis of these patients into fundamental new knowledge on IR trafficking and degradation.  Our current hope is that this in depth insight into IR metabolism might enable new therapeutic strategies to improve insulin receptor expression and function.  To fully understand the basis of human congenital insulin resistance, we have also begun to produce an allele series modeling mutations identified in our studies of human subjects with type 2 diabetes.  These new IR knock-in animals will enable studies of the role of insulin signaling in early development and over time during aging in multiple tissues involved in glucose metabolism.

We have also recently made the exciting discovery that the circadian gene network that functions as the core of the endogenous biological clock also regulates feeding and metabolism.  A major question is whether alteration of clock gene function within the brain or within peripheral tissues results in metabolic disease?  We are using behavioral, metabolic and molecular analyses to test various hypotheses that will delineate the relationship between circadian and metabolic pathways.

Research Topics

  • Cell mechanisms of insulin sensitivity and kinase regulation
  • Genetic models of type 2 diabetes
  • Regulation of body weight and metabolism by the circadian gene transcription network.

Selected Publications

  • Bass J, Steiner DF:  Insulin receptor folding.  In Insulin signaling: from cultured cells to animal models.  Harwood Academic Press. Invited review, 2002.  
  • Bass J, Turck C, Rouard M, Steiner DF 2000 Furin-mediated processing in the early secretory pathway: sequential cleavage and degradation of misfolded insulin receptors. Proc Natl Acad Sci U S A 97:11905-9
  • Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Thinakaran G, Lynn DG, Meredith SC, Sisodia SS: 2000 Familial British dementia: expression and metabolism of BRI. Ann N Y Acad Sci 920:93-9
  • Rouard M, Bass J, Grigorescu F, et al. 1999 Congenital insulin resistance associated with a conformational alteration in a conserved beta-sheet in the insulin receptor L1 domain. J Biol Chem 274:18487-91
  • Bass J, Chiu G, Argon Y, Steiner DF 1998 Folding of insulin receptor monomers is facilitated by the molecular chaperones calnexin and calreticulin and impaired by rapid dimerization. J Cell Biol 141:637-46